佐賀大学医学部附属病院は、佐賀県佐賀市の佐賀大学鍋島キャンパス内にある大学病院である。

During the past decade, Saga University Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 8 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saga University Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saga University Hospital" #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "University of the Ryukyus" with 2 trials as a collaborator, "Chukyo Hospital" with 1 trials as a collaborator and "Ebina General Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Saga University Hospital" are "Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Alport Syndrome" (1 trials). Many other conditions were trialed in "Saga University Hospital" in a lesser frequency.

Most popular intervention types in "Saga University Hospital" are "Drug" (22 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (4 trials), "Atezolizumab" (2 trials), "BMS-986165" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Saga University Hospital" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Saga University Hospital". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Saga University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saga University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".